Molecular mechanisms: Could omega-3 metabolite offer hope in battle against age-related diseases?

iStock / kalmukanin

A signalling molecule produced by the the omega-3 fatty acid DHA could be used to target age-related conditions and diseases including stroke and Alzheimer’s, new research suggests.

A greater understanding of docosahexaenoic acid (DHA) could lead to effective targets and therapies for a variety of diseases, according to a new review published in the Journal of Biological Chemistry.

The team from LSU Health New Orleans School of Medicine reported that DHA has been found to produce signalling molecules (docosanoids) when the body’s state of equilibrium is altered due to disease or injury.

One docosanoid in particular, Neuroprotectin D1 (NDP1), is said to protect neurons in the retina and brain, causing researchers to believe this could be a possible route of therapy.

“It is our hope that this knowledge will contribute to managing early stages of such devastating diseases as Alzheimer’s stroke, traumatic brain injury, age-related macular degeneration, Parkinson’s and others,” said lead researcher Professor Nicolas Bazan.

Omega-3 and health

Omega-3, found in foods such as salmon, tuna, algae and walnuts, is well-researched and has many suggested and established health benefits, including established EFSA claims relating to the the maintenance of normal vision, brain function, function of the heart, maintenance of normal blood triglycerides level normal blood pressure.

Furthermore, research has suggested that omega-3 may play a role in  preventing Alzheimer’s disease, reducing cardiovascular disease risk and decreasing mortality rates in postmenopausal women.

According to the omega-3 index, an 8% percentage of omega-3 fatty acids EPA (eicosapentaenoic acid) + DHA in red blood cells is desirable, while a score of 4% is considered a danger zone. 

DHA and NPD1 

The new review sheds light on the role of DHA and its NDP1 metabolite on homeostasis changes in the body.

According to the team behind the study, the molecule provokes neuroprotection in cases of early-stage Alzheimer’s disease and in experimental stroke. Administration of the molecule was also found to reduce stroke damage and also save tissue in the rim surrounding the stroke core, said Bazan and colleagues. 

Furthermore, in case of Alzheimer’s disease, NPD1’s inflammatory properties have been suggested to play a part in preventing the progression of the disease.

Previous research has shown clinical symptoms of early-stage Alzheimer’s include neuro-inflammation, damage to dendritic spines and problems with cell-to-cell communication, all of which coincide with decreased DHA levels in the brain.

Could DHA prevent cell death?

The US-based researchers suggest that NPD1’s inflammatory properties help restore a state of equilibrium in the body, aiding the recovery of cells, and preventing cell death.

“Cell death is considered to be reversible until a first ‘point-of-no-return’ checkpoint is passed,” said Bazan, who noted that although cells can die in multiple ways, by far the most studied forms of cell death are apoptosis and necrosis.

“In degenerative diseases like Alzheimer’s disease, Parkinson’s disease, age-related macular degeneration and stroke, dysregulation of apoptosis is a central event,” he said.

However, the team believes that NPD1 can prevent cells from reaching this ‘checkpoint’ in cell death activation pathways, including apoptosis, necrosis, necroptosis, pyroptosis, and pyrnecrosis.

“Understanding the molecular mechanisms of action of dietary essential fatty acids will lead to effective treatments of diseases and conditions such as stroke, Alzheimer’s disease, age-related macular degeneration, Parkinson’s disease, and other retinal and neurodegenerative diseases,” Bazan said.

Source: Journal of Biological Chemistry
“Molecular mechanisms of signalling via the docosanoid neuroprotectin D1 for cellular homeostasis and neuroprotection”
Published online, 14 June 2017, doi: 10.1074/jbc.R117.783076
Authors: Aram Asatryan and Nicolas G. Bazan

Related News

iStock

Prevention not a cure? Omega-3 in heart disease

© iStock/ stockdevil

Cannabinoids may be responsible for omega-3 anti-inflammatory effect: Study

Omega-3 could aid Alzheimer's prevention: Study

Omega-3 could aid Alzheimer's prevention: Study

©iStock

GM plant-derived omega-3 successfully cultivated on commercial scale

The current per capita spending on omega-3 supplements in Asia stands at US$0.49. ©iStock

Asia's 'huge potential' could create an extra $20bn of omega-3 sales

iStock/vadimguzhva

Improved omega-3 to omega-6 status during pregnancy may boost fetal health: Study

Miho Kikuchi

OPINION: Why optimal omega-3 and omega-6 ratios in the diet could balance the scales

Related Products

See more related products

Comments (1)

Corie - 11 Aug 2017 | 06:36

My husband is 80 years and has been suffering from PD for the past 15 years.

My husband is 80 years and has been suffering from PD for the past 15 years. Lately he started hallucinating and I didn't know how to handle the situation. He cannot sleep and tried to find and catch the imaginary people who he thinks are real. he was taken Entacapone with Levodopa, Carbidopa, and Pramipexole and started physical therapy to strengthen muscles. nothing was really working to help his condition.I took him off the Siferol (with the doctor’s knowledge) and started him on parkinson’s herbal formula i ordered from Health Herbal Clinic, his symptoms totally declined over a 5 weeks use of the Parkinsons disease natural herbal formula.i read reviews from other previous patients who used the herbal formula, my husband is now active, he can now go about daily exercise!! his symptoms so much reduced that now I hardly notice them.Visit there website www. healthherbalclinic. net or email Info@ healthherbalclinic. net

11-Aug-2017 at 18:36 GMT

Submit a comment

Your comment has been saved

Post a comment

Please note that any information that you supply is protected by our Privacy and Cookie Policy. Access to all documents and request for further information are available to all users at no costs, In order to provide you with this free service, William Reed Business Media SAS does share your information with companies that have content on this site. When you access a document or request further information from this site, your information maybe shared with the owners of that document or information.